Vote Scores
Filings read through

Phathom Pharmaceuticals, Inc.: how funds voted at the meeting of 3 Jun 2025

Ticker
PHAT
Meeting
Season
year to 30 June 2025
Filers reporting
222
Ballot items
4

222 filers on Form N-PX reported votes at the Phathom Pharmaceuticals, Inc. meeting of 3 Jun 2025. The records fall into 4 ballot items. The page lists them in ballot order: items of the company first, then proposals from security holders. Each bar shows how the reporting filers split. It is not the result of the meeting.

This meeting is in the year to 30 June 2025. The latest season on file is the year to 30 June 2026. The page of Phathom Pharmaceuticals, Inc. has the latest meeting.

If the reporting person has not received confirmation of the actual number of votes cast prior to filing a report on Form N-PX, the numbers reported may reflect the number of shares instructed to be cast. A reporting person is not required to amend a previously filed Form N-PX report if the reporting person subsequently receives confirmation of the actual number of votes cast.

The words of the SEC. Source: Form N-PX and its instructions, Special Instructions D.5 and D.8, copied on .

The words of this site: the filer writes each filing. The SEC does not say that it checked the votes. A lender does not vote shares that are on loan. A later filing (Form N-PX/A) can replace an earlier filing, and the site uses the latest.

The figures on this page count the filers that report on Form N-PX and the shares they reported. They do not count all votes cast at the meeting.

The page gives records. It gives no investment advice and no advice on how to vote.

Season on this page: year to 30 June 2025. Filings read through . How the figures are made

The ballot

ForAgainstAbstain, withhold or otherAmber tick: the part cast against management

  1. Item 1: Director elections

    2 nominees. 70.2% of the reported votes are for. 42 filers withheld from or voted against at least one nominee.

    300 vote records from 79 filers. 2 of the 75 filers that marked the item voted against management. 4 filers gave no management mark.

    • Positions of 29 fund families
    • For 10
    • Abstain or withhold 4
    • Split or no vote 15
    • Against management 1
  2. Item 2: Advisory vote on executive pay (say-on-pay)

    302 vote records from 216 filers. 72 of the 196 filers that marked the item voted against management. 20 filers gave no management mark.

    • Positions of 37 fund families
    • For 23
    • Against 14
    • Against management 14
  3. Item 3: Frequency of the say-on-pay vote

    One year: 193 filers. Abstain: 3 filers. For: 2 filers. Three years: 2 filers. Takenoaction: 1 filer. None: 1 filer.

    304 vote records from 217 filers. 3 of the 197 filers that marked the item voted against management. 20 filers gave no management mark.

    • Positions of 37 fund families
    • Split or no vote 37
  4. Item 4: Audit-related items (auditor ratification)

    136 vote records from 78 filers. 0 of the 75 filers that marked the item voted against management. 3 filers gave no management mark.

    • Positions of 29 fund families
    • For 28
    • Split or no vote 1

Positions of the fund families

A position is not the vote of each fund. The position of a family is the way most of the shares reported by its filers were voted. Funds of one family can vote in different ways.

KeyForAgainstAbstain or withholdSplit or no voteAgainst management

Fund families at Phathom Pharmaceuticals, Inc., meeting of 3 Jun 2025Families in name order. "Abstain" includes withhold. "Split" includes no vote. "No report" means that no filer of the family listed the item.
Fund family2. Say-on-pay3. Pay-vote frequency4. Auditor
AllianceBernsteinForSplitNo report
American CenturyAgainst, against managementSplitNo report
BairdForSplitNo report
BlackRock and iSharesForSplitFor
BNY MellonForSplitNo report
Brighthouse FundsForSplitFor
Charles SchwabAgainst, against managementSplitFor
Columbia ThreadneedleForSplitFor
DWSForSplitFor
EquitableAgainst, against managementSplitFor
FidelityForSplitFor
Global XAgainst, against managementSplitFor
Goldman SachsForSplitFor
Guggenheim and RydexForSplitFor
InvescoAgainst, against managementSplitFor
J.P. MorganForSplitNo report
Jackson National fundsAgainst, against managementSplitFor
John Hancock and ManulifeAgainst, against managementSplitFor
Lincoln FinancialForSplitFor
MassMutualAgainst, against managementSplitFor
Morgan Stanley, Eaton Vance and CalvertAgainst, against managementSplitFor
NationwideForSplitFor
Natixis and Loomis SaylesAgainst, against managementSplitNo report
Neuberger BermanAgainst, against managementSplitNo report
Northern Trust and FlexSharesForSplitFor
Nuveen and TIAAForSplitFor
Pacific Life fundsForSplitFor
PGIM and PrudentialAgainst, against managementSplitFor
PrincipalForSplitNo report
ProShares and ProFundsForSplitFor
Russell InvestmentsAgainst, against managementSplitSplit
SEIAgainst, against managementSplitFor
State Street and SPDRForSplitFor
T. Rowe PriceForSplitFor
VanguardForSplitFor
Victory CapitalForSplitFor
VoyaForSplitFor

Questions

How many filers reported votes at the Phathom Pharmaceuticals, Inc. meeting?
222 Form N-PX filers reported votes at the meeting of 3 Jun 2025. On say-on-pay, 72 of 196 filers that marked the item voted against management (36.7%).
Is this the result of the meeting?
No. The page counts the filers that report on Form N-PX, and the shares they reported. Phathom Pharmaceuticals, Inc. reports the result of a vote on Form 8-K.
Why does the page show counts only for director elections?
A director record names the nominee. This site has no page and no row about a person. For director elections it keeps the number of nominees and the split of votes.

Provenance: SEC EDGAR, Form N-PX and N-PX/A filings that list Phathom Pharmaceuticals, Inc. with a meeting date within three days of 3 Jun 2025. A proposal title is the most common wording among filers. Where a wording can name a person, the SEC category is shown. The filers wrote the filings. Filings read through .